|
"shao y y"的相關文件
顯示項目 336-345 / 396 (共40頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2019 |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Chang C.-J.; Lee Y.-H.; Lu L.-C.;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Chih-Hung Hsu; Lu L.-C.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2019 |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C; Chia-Chi Lin; Lin C.-Y; Hsieh M.-S; Kuo H.-Y; Lien M.-Y; Shao Y.-Y; Huang T.-C; Hsu C.-H. |
| 臺大學術典藏 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 國立成功大學 |
2019 |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou, W.-C.;Chen, J.-S.;Hung, C.-Y.;Lu, C.-H.;Shao, Y.-Y.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Yeh, S.-P.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Hsieh, R.-K. |
| 國立成功大學 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Lu L.-C.;Hsu, C.;Shao, Y.-Y.;Chao, Y.;Yen, C.-J.;Shih, I.-L.;Hung, Y.-P.;Chang, Chang C.-J.;Shen, Y.-C.;Guo, J.-C.;Liu, T.-H.;Hsu, C.-H.;Cheng, A.-L. |
| 國立成功大學 |
2019 |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, S.-F.;Rau, K.-M.;Shao, Y.-Y.;Yen, C.-J.;Wu, M.-F.;Chen, J.-S.;Chang, Chang C.-S.;Yeh, S.-P.;Chiou, T.-J.;Hsieh, R.-K.;Lee, M.-Y.;Sung, Y.-C.;Lee, K.-D.;Lai, P.-Y.;Yu, M.-S.;Hwang, W.-L.;Liu, T.-C. |
| 臺大學術典藏 |
2018-09-10T18:05:00Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao, Y.-Y.;Chen, B.-B.;Ou, D.-L.;Lin, Z.-Z.;Hsu, C.-H.;Wang, M.-J.;Cheng, A.-L.;Hsu, C.; BANG-BIN CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T15:38:30Z |
Key opioid prescription concerns in cancer patients: A nationwide study
|
Lin, C.-P.;Hsu, C.-H.;Fu, W.-M.;Chen, H.-M.;Lee, Y.-H.;Lai, M.-S.;Shao, Y.-Y.; CHIH-PENG LIN |
| 臺大學術典藏 |
2018-09-10T15:34:30Z |
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
|
Liang, Y.-H.;Wei, C.-H.;Hsu, W.-H.;Shao, Y.-Y.;Lin, Y.-C.;Chou, P.-C.;Cheng, A.-L.;Yeh, K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:40:50Z |
Ficusmicrochlorin A - C, two new methoxy lactone chlorins and an anhydride chlorin from the leaves of Ficus microcarpa
|
Chiu, H.-L.; Lu, T.-L.; Tzeng, C.-Y.; Lee, T.-H.; Lee, C.-K.; Shao, Y.-Y.; Chen, C.-R.; Chang, C.-I.; Kuo, Y.-H.; Lin, Huan-You; Chiu, Hsi-Lin; Lu, Te-Ling; Tzeng, Chih-Ying; Lee, Tzong-Huei; Lee, Ching-Kuo; Shao, Yi-Yuan; Chen, Chiy-Rong; Chang, Chi-I; Kuo, Yueh-Hsiung; Lin, H.-Y.; Chiu, H.-L.; Lu, T.-L.; Tzeng, C.-Y.; Lee, T.-H.; Lee, C.-K.; Shao, Y.-Y.; Chen, C.-R.; Chang, C.-I.; Kuo, Y.-H.; TZONG-HUEI LEE |
顯示項目 336-345 / 396 (共40頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目
|
